Category stocks

Astrazeneca Q2 Earnings Call Highlights

Key Points - Solid first-half performance: AstraZeneca reported revenue growth of 6% at constant exchange rates and 11% excluding generic-competition effects, while core EPS rose 11%. The company maintained its full-year outlook and reaffirmed its goal of reaching $80 bill

Entera Bio Raises $275M

Entera Bio raises $275M in private placement Entera Bio has priced a private placement, raising $275M. The company will issue 122.96M ordinary shares and 11.84M pre-funded warrants. The private placement was led by existing investor BVF Partners, with parti